Search the Newsreel

Earnings call transcript: Aquestive Therapeutics tops revenue views in Q2 2026

Aquestive Therapeutics reported Q2 2026 revenue of $13.82 million, exceeding analyst estimates, but also posted a wider-than-expected loss of $0.18 per share due to an $11.7 million debt extinguishment charge. The company remains on track to resubmit its Anaphylm NDA to the FDA in …

Invesque Sheds Seniors Housing Assets Amid Sharp Revenue Drop

Earnings Flash (IVQ-U.TO) Invesque Inc. Reports Q2 Revenue $2.7M

Queste Communications Reports July Cash Outflow on Major Investment Activity

Questerre Energy Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

HireQuest (HQI) Stock Jumps As Profit Margins Reset Higher

Aquestive Therapeutics Q2 Loss Widens, Revenue Rises

Aquestive Therapeutics reported a wider net loss in Q2 compared to the previous year, despite an increase in total revenue. The company also updated its full-year 2026 outlook, anticipating total revenue to be between $58 million and $62 million, with non-GAAP adjusted EBITDA expected …

Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates

Aquestive Therapeutics (NASDAQ:AQST) Releases Earnings Results, Misses Expectations By $0.08 EPS

Aquestive Therapeutics: Q2 Earnings Snapshot

This article provides a brief "Q2 Earnings Snapshot" for Aquestive Therapeutics. It is a very short piece, indicating that the company's Q2 earnings were reported.

Aquestive Therapeutics (AQST) grows revenue and refinances debt in Q2 2026

Questerre Energy Corp A (TSX: QEC

Aquestive Plans to Take Epi Film Back to FDA with Positive Data

Aquestive Therapeutics plans to resubmit its drug application for Anaphylm, an oral dissolving film for severe allergic reactions, to the FDA this fall. This follows the completion of two additional studies requested by the FDA, which have yielded positive results regarding revised packaging, ease …

Price to earnings forward of Alice Queen Limited – ASX:AQX

Aquestive Therapeutics (NASDAQ:AQST) Shares Up 7.1% - Here's Why

Aquestive Therapeutics (NASDAQ:AQST) saw its shares rise 7.1% to $4.595, with a market capitalization of approximately $574 million. The company's stock holds a consensus "Buy" rating from analysts with an average price target of $8.50, driven by its recent beat on quarterly earnings expectations. …

HireQuest’s Q2 revenue rises 6% as demand recovers

HireQuest (NASDAQ: HQI), a staffing and recruiting services franchisor, reported a 6% year-over-year increase in Q2 revenue, reaching $8.1 million, driven by an industry recovery. The company's net income soared by 154% to $2.7 million, largely due to a significant decrease in administrative expenses. …

HireQuest Q2 2026 earnings: Lower SG&A lifts profitability

HireQuest reported a significant increase in profitability for Q2 2026, with diluted EPS rising to $0.19 and net income more than doubling, primarily driven by a 31.9% reduction in SG&A expenses. Despite a reported decline in system-wide sales due to the MRINetwork divestiture, the …

Hirequest Inc (HQI) Stock News Today

Quest Diagnostics Incorporated (DGX) stock price, news, quote and history

HireQuest (HQI) boosts earnings as Adjusted EBITDA climbs and buybacks ramp

HireQuest (HQI) reported significantly increased profitability for Q2 and the first half of 2026, with net income more than doubling in Q2 and Adjusted EBITDA also seeing substantial growth. This improved performance occurred despite a modest revenue decrease year-to-date, primarily due to lower operating …

HireQuest, Inc. 2Q 2026: Revenue $8.1M, EPS $0.19— 10-Q Summary

HireQuest, Inc. (HQI) reported its second-quarter 2026 results, showing a 6% increase in revenue to $8.1M and a diluted EPS of $0.19, significantly up from $0.08 in the prior year. Net income rose by 154% to $2.69M. The revenue growth was primarily driven by …

Aquestive Therapeutics (AQST) Earnings Date and Reports 2026

Frequency Electronics, Inc. (98K.F) stock price, news, quote and history

This Yahoo Finance page provides a detailed overview of Frequency Electronics, Inc. (98K.F), including its current stock price, news, and historical data. It highlights the stock's significant performance, showing returns that have substantially outperformed the S&P 500 across various periods (YTD, 1-year, and 3-year). …

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film

Aquestive Therapeutics announced positive topline results from its human factors and pharmacokinetic studies for Anaphylm™ sublingual film, an epinephrine product for severe allergic reactions. These results support the planned resubmission of its New Drug Application (NDA) to the FDA in the third quarter of …

Form 8K Quetta Acquisition Corp Unit For: 10 August By Investing.com

This article from Investing.com reports on a Form 8K filing by Quetta Acquisition Corp for August 10th. The filing likely contains important financial or corporate information relevant to the company. The article provides the title and the date of the filing.

Tutor Perini, AAON, Onterris, Quest Resource, and Blink Charging Shares Skyrocket, What You Need To Know

Tutor Perini, AAON, Onterris, Quest Resource, and Blink Charging Shares Skyrocket, What You Need To Know What Happened? A number of stocks jumped in the after-market session after the July jobs report showed an unexpected loss of 23,000 jobs, signaling a cooling labor market. …

Bank of Queensland Announces AUD 0.15 Dividend for Ordinary Shareholders

HireQuest Q2 Results: Adjusted EPS beats estimates by 76.92%

Hirequest earnings beat by $0.09, revenue topped estimates

HireQuest, Inc. (HQI) Tops Q2 Earnings and Revenue Estimates

Earnings call transcript: HireQuest posts Q2 2026 beat as growth rebounds

HireQuest reported stronger-than-expected Q2 2026 results, with diluted EPS of $0.19 and revenue of $8.1 million, marking its first year-over-year revenue growth since Q3 2024. The company's stock rose significantly, trading near its 52-week high. Management expressed optimism for the rest of 2026, citing …

Insight Molecular Diagnostics: Q2 Earnings Snapshot

The provided content is not an article but rather a privacy notice or a placeholder. It does not contain any information about Insight Molecular Diagnostics or its Q2 earnings. Therefore, no meaningful summary can be generated.

HireQuest (NASDAQ:HQI) Announces Earnings Results

HIREQUEST ($HQI) Releases Q2 2026 Earnings

HireQuest Inc (HQI) is scheduled to release its Q2 2026 earnings on August 10, 2026, with revenue estimated at $7.08 million and earnings at $0.14 per share. While analyst price targets suggest an upside of 16.26%, GuruFocus's GF Value indicates a 19.09% downside. Revenue …

HireQuest Reports Financial Results for Second Quarter 2026

HireQuest Reports $2.7M Q2 Net Income Amid Recovering Staffing Demand